The inhibitors of the renin–angiotensin–aldosterone system (RASi), diuretics, calcium channel blockers (CCB), beta blockers (βB), aldosterone antagonists (AA), tritherapy, and more than three antihypertensive drugs were significantly more commonly used among subjects with CKD. The gene discussed is REN; the disease is chronic kidney disease.